Interim report January – March 2026

Q1 2026 net sales were 1.148 MSEK, down 10% from 1.274 MSEK a year earlier, while operating result improved slightly to -11.3 MSEK from -12.1 MSEK. The result for the period narrowed to -9.24 MSEK from -16.14 MSEK, and EPS came in at -0.53 versus -0.99 last year. Overall, the release shows modest operational improvement but still indicates continued losses.

Analysis

The key takeaway is not the incremental revenue decline; it’s that the cost base is still structurally too large for the current demand level, so each quarter is effectively a financing event rather than a growth story. A narrower operating loss with a weaker top line usually means management has found some variable-cost relief, but the business is still burning enough at the operating line that equity value is increasingly dependent on either a step-change in sales productivity or a balance-sheet reset. That shifts the market’s attention from quarterly P&L optics to runway, dilution, and covenant risk over the next 2-6 quarters.

For competitors, this is mildly positive in a very specific way: if this company is a participant in a concentrated niche, a slower burn rate can reduce near-term pricing aggression, but it also signals that the market is not yet in a consolidation phase where weaker players exit quickly. The second-order effect is that suppliers and channel partners likely remain cautious, demanding tighter payment terms or preferring counterparties with stronger liquidity, which can compound disadvantage for the weakest operator. If management wants to reverse the trend, the fastest path is not modest cost cutting; it is either a credible capital raise paired with a restructuring narrative or evidence of accelerating gross-margin expansion over the next 1-2 reporting cycles.

The contrarian view is that investors may be underweighting how much improvement can come from a smaller denominator effect if the business has already taken meaningful restructuring charges or fixed-cost rationalization. But that only matters if the next two quarters show operating losses stabilizing despite flat-to-up sales; otherwise, the market will start pricing the equity as a call option on survival rather than execution. In that setup, upside comes from a financing catalyst or strategic transaction, while downside comes from a failed turnaround that forces dilution at a depressed valuation within months, not years.

Key Decisions for Investors

• Avoid initiating long exposure here absent a visible liquidity catalyst; treat the equity as a high-dilution risk over the next 2-3 quarters until cash burn inflects.
• If liquidity runway is under 12 months, position for downside via put spreads or shorting into any post-earnings bounce; skew favors a sharp repricing on financing headlines.
• For event-driven accounts, watch for a strategic review or rights issue announcement within 30-90 days; that is the highest-probability catalyst for a tradable move, though with asymmetric dilution risk.
• Relative-value idea: pair short this name against a profitable peer in the same sub-sector with stable margins and stronger balance sheet, targeting 10-15% dispersion if the market starts discriminating on financing risk.
• If management guides to sequential EBITDA improvement for the next quarter, consider a small tactical long only after confirmation; risk/reward is favorable only if operating losses shrink faster than revenue, implying a credible turnaround inflection.